A Retrospective Analysis of the Effect of Irinotecan-Based Regimens in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes

BACKGROUND: At present, patients with metastatic breast cancer (MBC) have few treatment options after receiving anthracyclines and taxanes. Studies have shown that irinotecan has modest systemic activity in some patients previously treated with anthracyclines and taxanes. This study aimed to evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales: Suo, Jiaojiao, Zhong, Xiaorong, He, Ping, Zheng, Hong, Tian, Tinglun, Yan, Xi, Luo, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645637/
https://www.ncbi.nlm.nih.gov/pubmed/34881172
http://dx.doi.org/10.3389/fonc.2021.654974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645637/
https://www.ncbi.nlm.nih.gov/pubmed/34881172
http://dx.doi.org/10.3389/fonc.2021.654974

Ejemplares similares